Cargando…

Computational Trials: Unraveling Motility Phenotypes, Progression Patterns, and Treatment Options for Glioblastoma Multiforme

Glioblastoma multiforme is a malignant brain tumor with poor prognosis and high morbidity due to its invasiveness. Hypoxia-driven motility and concentration-driven motility are two mechanisms of glioblastoma multiforme invasion in the brain. The use of anti-angiogenic drugs has uncovered new progres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raman, Fabio, Scribner, Elizabeth, Saut, Olivier, Wenger, Cornelia, Colin, Thierry, Fathallah-Shaykh, Hassan M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710507/ https://www.ncbi.nlm.nih.gov/pubmed/26756205 http://dx.doi.org/10.1371/journal.pone.0146617

Ejemplares similares

Effects of Anti-Angiogenesis on Glioblastoma Growth and Migration: Model to Clinical Predictions
por: Scribner, Elizabeth, et al.
Publicado: (2014)

Single Cell Mathematical Model Successfully Replicates Key Features of GBM: Go-Or-Grow Is Not Necessary
por: Scribner, Elizabeth, et al.
Publicado: (2017)

Prognostic Relevance of Cytochrome c Oxidase in Primary Glioblastoma Multiforme
por: Griguer, Corinne E., et al.
Publicado: (2013)

Unraveling unique and common cell type-specific mechanisms in glioblastoma multiforme
por: Fathima, Samreen, et al.
Publicado: (2021)

Apatinib for recurrent/progressive glioblastoma multiforme: A salvage option
por: Zhang, Hong-Hong, et al.
Publicado: (2022)

Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)
por: Yalamarty, Satya Siva Kishan, et al.
Publicado: (2023)

Dynamics of the Drosophila Circadian Clock: Theoretical Anti-Jitter Network and Controlled Chaos
por: Fathallah-Shaykh, Hassan M.
Publicado: (2010)

New treatment options in the management of glioblastoma multiforme: a focus on bevacizumab
por: Moustakas, Argirios, et al.
Publicado: (2010)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

Immune phenotypes predict survival in patients with glioblastoma multiforme
por: Mostafa, Haouraa, et al.
Publicado: (2016)

Metformin and temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models
por: Valtorta, Silvia, et al.
Publicado: (2017)

Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)

Incidentalomas to glioblastoma multiforme
por: Sachdev, Bobby, et al.
Publicado: (2014)

Tracking of time-varying genomic regulatory networks with a LASSO-Kalman smoother
por: Khan, Jehandad, et al.
Publicado: (2014)

Radiogenomic Mapping of Edema/Cellular Invasion MRI-Phenotypes in Glioblastoma Multiforme
por: Zinn, Pascal O., et al.
Publicado: (2011)

Significant Systemic Insulin Resistance is Associated With Unique Glioblastoma Multiforme Phenotype
por: Laviv, Yosef, et al.
Publicado: (2023)

Intussusception following treatment for glioblastoma multiforme: A rare association
por: Raman, V Shankar, et al.
Publicado: (2014)

Tectal plate glioblastoma multiforme
por: Nemer, Michael D., et al.
Publicado: (2011)

Bilateral cystic glioblastoma multiforme
por: Kumar, Sushil, et al.
Publicado: (2013)

Glioblastoma Multiforme Stem Cells
por: Dimov, Irena, et al.
Publicado: (2011)

Atypical Presentation of Glioblastoma Multiforme
por: Al-Janabi, Wissam, et al.
Publicado: (2018)

Nanotechnology for Treatment of Glioblastoma Multiforme
por: Michael, Justin S., et al.
Publicado: (2018)

The complement system in glioblastoma multiforme
por: Bouwens van der Vlis, T. A. M., et al.
Publicado: (2018)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Survival Analysis of Glioblastoma Multiforme
por: Witthayanuwat, Supapan, et al.
Publicado: (2018)

Advances in Immunotherapy for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2017)

Targeted Nanotechnology in Glioblastoma Multiforme
por: Glaser, Talita, et al.
Publicado: (2017)

Prion Protein in Glioblastoma Multiforme
por: Ryskalin, Larisa, et al.
Publicado: (2019)

Current Immunotherapies for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2021)

Glioblastoma Multiforme Masquerading as Stroke
por: Remley, William, et al.
Publicado: (2021)

Advances in immunotherapy for glioblastoma multiforme
por: Mahmoud, Ahmad Bakur, et al.
Publicado: (2022)

Vascular Endothelial Growth Factor, Irradiation, and Axitinib Have Diverse Effects on Motility and Proliferation of Glioblastoma Multiforme Cells
por: Krcek, Reinhardt, et al.
Publicado: (2017)

c-Src and Neural Wiskott-Aldrich Syndrome Protein (N-WASP) Promote Low Oxygen-Induced Accelerated Brain Invasion by Gliomas
por: Tang, Zhuo, et al.
Publicado: (2013)

Evaluation of RANO Criteria for the Assessment of Tumor Progression for Lower-Grade Gliomas
por: Raman, Fabio, et al.
Publicado: (2023)

Correction: Radiogenomic Mapping of Edema/Cellular Invasion MRI-Phenotypes in Glioblastoma Multiforme
por: Zinn, Pascal O., et al.
Publicado: (2012)

Simultaneous impact of atorvastatin and mesenchymal stem cells for glioblastoma multiform suppression in rat glioblastoma multiform model
por: Goodarzi, Arash, et al.
Publicado: (2020)

Secondary gliosarcoma after the treatment of primary glioblastoma multiforme
por: Andaloussi-Saghir, Khalid, et al.
Publicado: (2011)

Approximate kernel reconstruction for time-varying networks
por: Ditzler, Gregory, et al.
Publicado: (2019)

Canadian recommendations for the treatment of glioblastoma multiforme
por: Mason, W.P., et al.
Publicado: (2007)

Targeting Metabolic Remodeling in Glioblastoma Multiforme
por: Wolf, Amparo, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_5i2oomd993c2k8ucb8hbflkv0v